CYP19A1 and breast cancer: ,189 Similarly, in postmenopausal women, there is a substantial correlation between elevated levels of aromatase and adipocyte size and indicators of subclinical systemic inflammation (IL-6),189 which promotes ER+ breast cancer cell survival and malignancy.